December 16, 2016 For decades, doctors and scientists have pursued practical and affordable treatments for cancer. For the most part, they have been met with uneven success, but biotechnology companies, Cellectis, Editas Medicine, and Intellia Therapeutics, are working on a new method of treatment with wide-reaching implications. The discovery that the immune system fights … Continue reading Engineering T-Cells to Cure Cancer